A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection

计划入组 5,485 人 · 首次发布于 2024 年 11 月 4 日

Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

计划入组 150 人 · 首次发布于 2022 年 5 月 13 日

Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

计划入组 43 人 · 首次发布于 2022 年 5 月 13 日

mRNA COVID-19 Vaccine

mRNA vaccine (COVID-19)

COVID-19 mRNA vaccine

E-MO BIOLOGY INC.

United States

BioNTech SE

Germany

BEAT COVID LLC

United States

Vaxart's Oral COVID-19 Vaccine Candidate Receives Positive DSMB Review, Advancing Phase 2b Trial

Dynavax Secures Exclusive License to Vaxart's Oral COVID-19 Vaccine in $25 Million Deal

Japan Approves CSL and Arcturus' Self-Amplifying mRNA COVID-19 Vaccine, Kostaive